Evidence map›Paper›PMID 28742148›Full record

ArticlePLoS pathogens2017

Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.

Damien Groussaud, Mostafa Khair, Armelle I Tollenaere, Laetitia Waast, Mei-Shiue Kuo, Marianne Mangeney, Christophe Martella, Yann Fardini, Solène Coste, Mouloud Souidi and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Iron down-regulates leptin by suppressing proteinThe Journal of biological chemistry · 2019
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Damien GroussaudINSERM, U1016, Institut Cochin, Paris, France.
Mostafa KhairINSERM, U1016, Institut Cochin, Paris, France.ORCID http://orcid.org/0000-0001-6555-0642
Armelle I TollenaereINSERM, U1016, Institut Cochin, Paris, France.
Laetitia WaastINSERM, U1016, Institut Cochin, Paris, France.
Mei-Shiue KuoINSERM, U1016, Institut Cochin, Paris, France.
Marianne MangeneyINSERM, U1016, Institut Cochin, Paris, France.
Christophe MartellaINSERM, U1016, Institut Cochin, Paris, France.
Yann FardiniINSERM, U1016, Institut Cochin, Paris, France.ORCID http://orcid.org/0000-0002-6800-1777
Solène CosteINSERM, U1016, Institut Cochin, Paris, France.ORCID http://orcid.org/0000-0003-2845-8876
Mouloud SouidiINSERM, U1016, Institut Cochin, Paris, France.
Laurence BenitINSERM, U1016, Institut Cochin, Paris, France.ORCID http://orcid.org/0000-0002-9723-0245
Claudine PiqueINSERM, U1016, Institut Cochin, Paris, France.ORCID http://orcid.org/0000-0001-8690-2440
Tarik IssadINSERM, U1016, Institut Cochin, Paris, France.
Délégation Paris 5 · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The viral Tax oncoprotein plays a key role in both Human T-cell lymphotropic virus type 1 (HTLV-1)-replication and HTLV-1-associated pathologies, notably adult T-cell leukemia. Tax governs the transcription from the viral 5'LTR, enhancing thereby its own expression, via the recruitment of dimers of phosphorylated CREB to cAMP-response elements located within the U3 region (vCRE). In addition to phosphorylation, CREB is also the target of O-GlcNAcylation, another reversible post-translational modification involved in a wide range of diseases, including cancers. O-GlcNAcylation consists in the addition of O-linked-N-acetylglucosamine (O-GlcNAc) on Serine or Threonine residues, a process controlled by two enzymes: O-GlcNAc transferase (OGT), which transfers O-GlcNAc on proteins, and O-GlcNAcase (OGA), which removes it. In this study, we investigated the status of O-GlcNAcylation enzymes in HTLV-1-transformed T cells. We found that OGA mRNA and protein expression levels are increased in HTLV-1-transformed T cells as compared to control T cell lines while OGT expression is unchanged. However, higher OGA production coincides with a reduction in OGA specific activity, showing that HTLV-1-transformed T cells produce high level of a less active form of OGA. Introducing Tax into HEK-293T cells or Tax-negative HTLV-1-transformed TL-om1 T cells is sufficient to inhibit OGA activity and increase total O-GlcNAcylation, without any change in OGT activity. Furthermore, Tax interacts with the OGT/OGA complex and inhibits the activity of OGT-bound OGA. Pharmacological inhibition of OGA increases CREB O-GlcNAcylation as well as HTLV-1-LTR transactivation by Tax and CREB recruitment to the LTR. Moreover, overexpression of wild-type CREB but not a CREB protein mutated on a previously described O-GlcNAcylation site enhances Tax-mediated LTR transactivation. Finally, both OGT and OGA are recruited to the LTR. These findings reveal the interplay between Tax and the O-GlcNAcylation pathway and identify new key molecular actors involved in the assembly of the Tax-dependent transactivation complex.

Indexed as

Acetylglucosaminebeta-N-AcetylhexosaminidasesCyclic AMP Response Element-Binding ProteinGene Expression Regulation, ViralGene Products, taxHost-Pathogen InteractionsHTLV-I InfectionsHumansHuman T-lymphotropic virus 1N-AcetylglucosaminyltransferasesProtein Processing, Post-TranslationalT-LymphocytesTranscription, GeneticAcetylglucosaminebeta-N-AcetylhexosaminidasesCyclic AMP Response Element-Binding ProteinGene Products, taxhexosaminidase CN-AcetylglucosaminyltransferasesO-GlcNAc transferasetax protein, Human T-lymphotrophic virus 1

Identifiers

PMID28742148
PMCPMC5542696
OpenAlexW2737014306

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.